Successful treatment of an advanced hepatocellular carcinoma with the long-acting somatostatin analog lanreotide.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 9934776.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Treatment options for hepatocellular cancer apart from surgical resection are limited because of the drug-refractory nature of this disease. Little is known about the role of somatostatin-receptors in hepatocellular cancer, and somatostatin analogs have not been investigated for treatment of this malignancy. We present the case of a 68-yr-old male, who was successfully treated with the long-acting somatostatin analog lanreotide.
Medical subject headings
- Antineoplastic Agents
- Carcinoma, Hepatocellular
- Liver Neoplasms
- Peptides, Cyclic
- Somatostatin